These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4973519)

  • 1. Management of coronary artery disease.
    Br Med J; 1969 Jan; 1(5635):37-8. PubMed ID: 4973519
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors of coronary heart disease. New results in the Federal Republic of Germany.
    Schettler G; Nüssel E
    G Ital Cardiol; 1974; 4(3):366-72. PubMed ID: 4844208
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for angina.
    Br Med J; 1969 Jun; 2(5658):677-8. PubMed ID: 4977329
    [No Abstract]   [Full Text] [Related]  

  • 4. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Progress' in the treatment and prevention of coronary heart disease.
    Russek HI
    Am Fam Physician; 1971 Sep; 4(3):68-74. PubMed ID: 4999280
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study.
    Kannel WB
    G Ital Cardiol; 1974; 4(1):123-37. PubMed ID: 4824624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carbohydrate metabolism disorder in ischemic cardiopathies].
    Kleinerman L; Apetrei E; Iliescu M; Cionca H; Constantinescu S; Zătreanu Y
    Med Interna (Bucur); 1970 Sep; 22(9):1071-8. PubMed ID: 5491376
    [No Abstract]   [Full Text] [Related]  

  • 8. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

  • 9. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for use of lipid-lowering drugs.
    Dayton S
    Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary arteriosclerosis in young adults].
    Bretholz A; Moccetti T; Lichtlen P
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1600-1. PubMed ID: 4422932
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myocardial infarct in the young: current state of knowledge and considerations on the possibilities of work resumption].
    Todaro A; Tomasini M
    Med Lav; 1984; 75(2):87-100. PubMed ID: 6379399
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertriglyceridemia and premature coronary artery disease.
    Harley CH
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():93-7. PubMed ID: 4604548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Artherosclerotic ischemic coronary disease. Etiopathogenic considerations].
    Kamel D; Vaissman I; Veloso E; Rotman F; Manhães H
    Arq Bras Endocrinol Metabol; 1969 Dec; 18(3):163-84. PubMed ID: 4935190
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous nitroglycerin in acute coronary artery disease.
    Marrott PK; Nairn PL; Dawson CJ; Martin SM
    N Z Med J; 1982 Sep; 95(716):663-6. PubMed ID: 6813780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical perspectives of coronary artery disease.
    Russek HI
    Angiology; 1967 Jan; 18(1):15-22. PubMed ID: 4959655
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial hypercholesterolaemic xanthomatosis and coronary heart disease in a ten-year-old girl.
    Miettinen M
    Ann Paediatr Fenn; 1967; 13(1):35-8. PubMed ID: 6079714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.